Guest:
Jessica Stieritz, MD
Resident - Abington Family Medicine Residency Program 
Jefferson Health

2. A treat-to-target strategy versus symptom-driven management of gout in the Netherlands (GO TEST Overture): a multicentre, open-label, pragmatic, superiority, randomized controlled trial. Lancet Rheumatology 2026. Discussion by:

Guest:
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney  Kimmel  Medical College Thomas Jefferson University
Associate Director - Family Medicine Residency Program
Jefferson Health – Abington

3. Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients. NEJM 2026 Discussion by: 

Guest:
Steven Leonard, MD 
Resident - Abington Family Medicine Residency Program 
Jefferson Health

Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. 

This Podcast Episode does not offer CME/CE Credit. 

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

Guest:
Susan Kucher, MD
Program Director - Abington Family Medicine Residency Program 
Jefferson Health

2. Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes Results From the VESALIUS-CV Trial. JAMA. Discussion by:

Guest:
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney  Kimmel  Medical College Thomas Jefferson University
Associate Director - Family Medicine Residency Program
Jefferson Health – Abington

3. Prevalence of Youth Overweight, Obesity, and Severe Obesity. JAMA Network Open. Discussion by:  

Guest:
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney  Kimmel  Medical College Thomas Jefferson University
Associate Director - Family Medicine Residency Program
Jefferson Health – Abington

4. A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide. New England Journal of Medicine 2026. Discussion by:

Guest:
Griffin Johnson, MD
Resident - Abington Family Medicine Residency Program 
Jefferson Health

Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. 

This Podcast Episode does not offer CME/CE Credit. 

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

Guest:
Erin Russell, MD 
Resident - Abington Family Medicine Residency Program 
Jefferson Health - Abington

2. A guide to consumer-grade wearables in cardiovascular clinical care and population health for non-experts. Discussion by: 

Guest:
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney  Kimmel  Medical College Thomas Jefferson University
Associate Director - Family Medicine Residency Program
Jefferson Health – Abington

3. Enhanced Detection and Prompt Diagnosis of Atrial Fibrillation Using Apple Watch: A Randomized Controlled Trial. Journal of the American College of Cardiology 2026 Discussion by: 

Guest:
Jessica Stieritz, MD 
Resident - Abington Family Medicine Residency Program 
Jefferson Health - Abington

Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. 

This Podcast Episode does not offer CME/CE Credit. 

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

Guest:
Phillip Leiberman, MD
Resident Family Medicine Residency Program 
Jefferson Health - Abington

2. The Effect of Substituting Wate for Artificially Sweetened Beverages on Glycemic and Weight Measures in People With Type 2 Diabetes: The Study of Drinks With Artificial Sweeteners (SODAS), a Randomized Trial – Diabetes Care 2025. Discussion by: 

Guest:
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney  Kimmel  Medical College Thomas Jefferson University
Associate Director - Family Medicine Residency Program
Jefferson Health – Abington

3. Caffeinated Coffee Consumption or Abstinence to Reduce Atrial Fibrillation The DECAF
Randomized Clinical Trial – JAMA 2025. Discussion by: 

Guest:
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney  Kimmel  Medical College Thomas Jefferson University
Associate Director - Family Medicine Residency Program
Jefferson Health – Abington

4. Exercise for the Treatment of Depression. Cochrane Database of Systematic Reviews 2026 Discussion by:

Guest:
Aaron Sutton - Behavioral Specialist 
Family Medicine Residency Program
Chief Wellness Officer for Graduate Medical Education 
Jefferson Health – Abington

Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. 

This Podcast Episode does not offer CME/CE Credit. 

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

Guest:
Max Schidt, MD
Resident - Family Medicine Residency Program
Jefferson Health - Abington

2. One vs two dose HPV vaccination for prevention of HPV infection – The New England Journal of Medicine 2025. Discussion by:

Guest:
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney  Kimmel  Medical College Thomas Jefferson University
Associate Director - Family Medicine Residency Program
Jefferson Health – Abington

3. The Surpass CVOT trial for prevention of MACE in people with Diabetes – The New England Journal of Medicine 2025. Discussion by:

Guest:
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney  Kimmel  Medical College Thomas Jefferson University
Associate Director - Family Medicine Residency Program
Jefferson Health – Abington

4. The New American Cancer Society Guidelines for Screening for cervical cancer – that includes self swab for HPV. Discussion by:

Guest:
Amy Clouse, MD 
Associate Director - Family Medicine Residency Program 
Jefferson Health – Abington

Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. 

This Podcast Episode does not offer CME/CE Credit. 

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

https://www.mycme.com/courses/responding-to-the-science-biologics-in-practice-in-copd-10511

Summary
This enduring podcast activity provides pulmonologists and clinicians managing COPD with timely updates on the evolving role of biologics management. Featuring expert discussions, the program explores recent GOLD guideline revisions, the integration of new and emerging biologic therapies, and evidence-based decision-making based on clinical trial data and real-world practice.

Covering guidelines, clinical trials, and clinical scenario, this activity emphasizes the translation of complex data into practical strategies. Learners will gain improved knowledge and competence related to patient selection, eosinophil thresholds, and clinical decision making.

This podcast was recorded and is being used with permission of the presenters.

Learning Objectives

• Discuss recent evidence surrounding the use of biologic agents in the management of patients with COPD, including patient populations and outcomes
• Integrate the use of biologic agents into the management of patients with COPD based on guidelines and clinical evidence for new and emerging agents

This activity is accredited for CME/CE Credit
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here. 

Disclosure of Commercial Support
This educational activity is supported by an independent medical education grant from GSK and an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

https://www.mycme.com/courses/adhd-sleep-and-symptom-control-10355

Summary
Early-morning symptom control remains a critical gap in ADHD management, often contributing to family stress and impaired daily functioning. In this podcast/webcast activity, Dr. Joel Young and Jo Hughes, DMSc, PA-C, CAQ-PSY, explore the limitations of traditional ADHD medications in achieving full-day coverage and discuss available strategies to improve early-morning outcomes. Learners will gain practical insights into the clinical use of nighttime-dosed medications, including an innovative delayed-release/extended-release stimulant, and understand the pharmacologic characteristics that contribute to its efficacy in providing sustained symptom control.

This podcast was recorded and is being used with permission of the presenters.

Learning Objective

• Examine the ADHD treatment options that use nighttime dosing to achieve full-day symptom control

This activity is accredited for CME/CE Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which includes 0.50 hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is supported by an educational grant from Collegium Pharmaceutical, Inc.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

https://www.mycme.com/courses/personalized-antidepressant-choices-for-better-outcomes-in-mdd-10266

Summary
Emphasizing a measurement-based, patient-centered model, this is an enduring podcast/webcast designed for psychiatrists who seek to refine their approach to managing major depressive disorder (MDD). Despite an expanding array of pharmacologic options, many patients continue to experience side effects and residual symptoms that undermine adherence and long-term recovery. Led by Drs. Gregory Mattingly and Gerald Maguire, this activity equips clinicians with evidence-based strategies to compare the nuanced risk–benefit profiles of antidepressants and apply them to individualized treatment plans.

This podcast was recorded and is being used with permission of the presenters.

Learning Objectives

• Assess the risk–benefit profiles of available antidepressants, including their impact on residual symptoms, to optimize treatment decisions for patients with MDD
• Implement personalized, measurement-based treatment strategies for patients with MDD to address residual symptoms, promote adherence, and improve outcomes

This activity is accredited for CME/CE Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.75 hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

Guest:
Anupriya Grover Wenk, DO
Faculty - Family Medicine Residency Program
Jefferson Health - Abington

2. Evolocumab in Patients without a Previous Myocardial Infarction or Stroke – The New England Journal of Medicine 2025. Discussion by:

Guest:
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney  Kimmel  Medical College Thomas Jefferson University
Associate Director - Family Medicine Residency Program
Jefferson Health – Abington

3. AI-Powered Lifestyle Intervention vs Human Coaching in the Diabetes Prevention Program – JAMA. Discussion by:

Guest:
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney  Kimmel  Medical College Thomas Jefferson University
Associate Director - Family Medicine Residency Program
Jefferson Health – Abington

4. Incremental effect of healthy lifestyle habits when taking GLP-1 RA medications on Cardiac Risk Reduction.  Discussion by:

Guest:
Joe Gonella, MD
Resident– Family Medicine Residency Program
Jefferson Health – Abington

Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. 

This Podcast Episode does not offer CME/CE Credit. 

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

https://www.mycme.com/courses/personalizing-adhd-management-using-methylphenidate-10448

Summary
Effective ADHD management demands more than symptom control—it requires personalized treatment strategies aligned with the patient’s unique daily functional needs. Through clinical case examples and pharmacologic comparisons, learners will explore how tailoring treatment using immediate-release (IR), extended-release (ER), and delayed-release/extended-release (DR/ER) methylphenidate (MPH) formulations can optimize symptom control aligned with patients’ daily routines and responsibilities. In this podcast/webcast activity, Joel Young, MD, and Jo Hughes, DMSc, PA-C, CAQ-PSY will highlight practical strategies for implementing personalized ADHD treatment plans, with a focus on the unique benefits of evening-dosed DR/ER-MPH in addressing early-morning and evening functional impairments.

This podcast was recorded and is being used with permission of the presenters.

Learning Objectives

• Evaluate the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of ER-, DR/ER-, and IR-MPH formulations to implement safe, effective, and personalized ADHD treatment decisions.
• Discuss individualization of ADHD treatment plans by selecting MPH formulations based on PK profiles, patient characteristics, and functional goals to optimize symptom control and adherence.

This activity is accredited for CME/CE Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which includes 0.50 hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is supported by an educational grant from Collegium Pharmaceutical, Inc.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

2. Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Obesity – The New England Journal of Medicine 2025. Discussion by:
Guest:
Ajay Rau, MD
Chief - Section of Endocrinology, Diabetes and Metabolism
Lewis Katz School of Medicine at Temple University

3. Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation. New England Journal Of Medicine 2025.  Discussion by:
Guest:
Jasmin Walker, MD 
Resident – Family Medicine Residency Program 
Jefferson Health – Abington

Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. 

This Podcast Episode does not offer CME/CE Credit. 

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

2. Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2
Diabetes. – The New England Journal of Medicine 2025.Discussion by:
Guest:
Samantha Traslaviña, DO
Resident– Family Medicine Residency Program
Jefferson Health – Abington

3. Cycling and education intervention versus usual physiotherapy care for the treatment of hip osteoarthritis in the UK (CLEAT): a pragmatic, randomised, controlled trial. Lancet Rheumatology 2025. Discussion by:
Guest:
Sean Cleary, DO 
Resident– Family Medicine Residency Program 
Jefferson Health – Abington

Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. 

This Podcast Episode does not offer CME/CE Credit. 

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

2. Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial.  New England Journal of Medicine 2025 Discussion by:
Guest:
Donna Ryan, MD
Professor Emerita at Pennington Biomedical
Baton Rouge, LA, USA

3. Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer’s disease: a randomized, controlled clinical trial. Alzheimer’s Research & Therapy.  Discussion by:
Guest:
Kathryn Donnelly, DO
Resident– Family Medicine Residency Program
Jefferson Health – Abington

Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. 

This Podcast Episode does not offer CME/CE Credit. 

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

https://www.mycme.com/courses/personalizing-care-identifying-the-right-patients-for-new-treatments-10268

Summary
Dr. Genevieve Neal-Perry and Dr. Andrea Singer focus on practical strategies in the personalized management of menopausal vasomotor symptoms (VMS). The discussion covers the importance of routine and individualized screening for VMS, with attention to healthcare disparities and the diverse ways menopause is discussed and experienced across populations, before covering patient selection criteria for newer non-hormonal treatments.

Content Update Disclaimer: Since the recording of this and the accompanying podcast, the FDA has approved elinzanetant, an NK1/3 receptor antagonist for the treatment of menopausal VMS.

This podcast was recorded and is being used with permission of the presenters.

Learning Objectives

• Integrate routine and individualized screening methods to identify patients with menopausal VMS, with attention to healthcare disparities
• Integrate new and emerging agents into the treatment of women with menopausal VMS, based on patient characteristics and preference

This activity is accredited for CME/CE Credit
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is supported in part by an educational grant from Bayer HealthCare Pharmaceuticals Inc.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

https://www.mycme.com/courses/targeting-cause-emerging-therapies-menopausal-vms-10267

Summary
This enduring podcast activity explores groundbreaking advancements in the treatment of menopausal vasomotor symptoms (VMS), emphasizing non-hormonal therapies. Dr. Andrea Singer and Dr. Genevieve Neal-Perry discuss the underlying biology of menopause, particularly the role of neurokinin (NK) receptors, and introduces the science behind new therapeutic agents, as well as their clinical trial data.

Content Update Disclaimer: Since the recording of this and the accompanying podcast, the FDA has approved elinzanetant, an NK1/3 receptor antagonist for the treatment of menopausal VMS.

This podcast was recorded and is being used with permission of the presenters.

Learning Objective
Discuss the clinical trial data for new and emerging non-hormonal therapies

This activity is accredited for CME/CE Credit
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is supported in part by an educational grant from Bayer HealthCare Pharmaceuticals Inc.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. 

This Podcast Episode does not offer CME/CE Credit. 

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

https://www.mycme.com/courses/strategies-and-real-world-impact-of-the-stimulant-crisis-10220

Summary
The stimulant medication shortage has introduced new challenges in managing ADHD, affecting both patients’ access to essential treatments and clinicians’ ability to provide consistent care. In this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Roger McIntyre explore the impact of these shortages, particularly on cognitive functioning, treatment continuity, and daily life for individuals with ADHD. Their discussion also examines stimulant misuse and diversion, looking at trends in medication sourcing, formulations most susceptible to abuse, and strategies to reduce the risk of misuse. By the end of the episode, learners will be equipped with timely insights and real-world tools to optimize ADHD management amid evolving supply and safety challenges.

This podcast was recorded and is being used with permission of the presenters.

Learning Objectives
At the conclusion of this activity, participants should be better able to:

• Describe the impact of stimulant shortages on individuals with ADHD
• Incorporate best-practice clinical strategies to minimize the risk of stimulant misuse in the treatment of ADHD

This activity is accredited for CME/CE Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which includes 0.50 hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This activity is not supported by an educational grant.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

http://mycme.com/courses/the-cognitive-side-of-major-depressive-disorder-10221

Summary
Despite significant improvements in mood symptoms, many patients with MDD continue to experience persistent residual symptoms—particularly cognitive impairments—that hinder full functional recovery. In this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Roger McIntyre discuss the often-overlooked role of cognitive dysfunction in MDD recovery, highlighting how these impairments correlate strongly with reduced workplace productivity, social withdrawal, and elevated relapse risk, ultimately impeding long-term outcomes. Their conversation provides listeners with an in-depth understanding of the presentation of cognitive impairment and residual symptoms in MDD, as well as strategies to foster resilience, enhance patient engagement, and promote functional recovery.

This podcast was recorded and is being used with permission of the presenters.

Learning Objectives
At the conclusion of this activity, participants should be better able to:

• Recognize the clinical significance of residual symptoms in MDD, with a focus on cognitive impairment, and their impact on patient functioning and treatment outcomes

This activity is accredited for CME/CE Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.25 hours of pharmacology).

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

This podcast was recorded and is being used with permission of the presenters.

Learning Objectives
At the conclusion of this activity, participants should be better able to:

• Discuss emerging data on GLP-1 RA therapy for CKD progression in T2D
• Implement guideline-based care to minimize CV risk and CKD progression

This activity is accredited for CME/CE Credit
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This activity is supported by an educational grant from Novo Nordisk.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

2. Creatine monohydrate pilot in Alzheimer’s: Feasibility, brain creatine, and cognition. Alzheimer’s Dement. 2025. Discussion by:
Guest:
Michael Devano, DO 
Attending Family Physician 
Christiana Care Health System

3. Structured Exercise after Adjuvant Chemotherapy for Colon Cancer. The New England Journal of Medicine. Discussion by:
Guest:
Joseph Gonnella, MD 
Resident– Family Medicine
Residency Program, Jefferson Health – Abington

Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. 

This Podcast Episode does not offer CME/CE Credit. 

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

Learning Objectives
At the conclusion of this activity, participants should be better able to:

• Assess the disease burden and impact on QoL in patients with CSU
• Evaluate current and emerging therapies for CSU

This activity is accredited for CME/CE Credit
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This activity is supported by an independent educational grant from Sanofi and Regeneron Pharmaceuticals.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

Learning Objectives
At the conclusion of this activity, participants should be better able to:

• Review the relationship between inflammation, exacerbation, and disease progression in COPD, noting different inflammatory endotypes of patients with COPD
• Discuss recent evidence surrounding the use of biologic agents in the management of patients with COPD and type 2 inflammation
• Integrate current guidelines with clinical data on new and emerging agents for the management of COPD, distinguishing patients with and without markers of type 2 inflammation

This activity is accredited for CME/CE Credit
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

2. Genitourinary Syndrome of Menopause: AUA/SUFU/AUGS Guideline (2025).
Discussion by: Discussion by:
Guest:
Anupriya Grover-Wenk, DO 
Faculty– Family Medicine Residency Program
Jefferson Health – Abington

3. Liberal fluid intake versus fluid restriction in chronic heart failure: a randomized clinical trial. Discussion by:
Guest:
Joseph Gonnella, MD
Resident– Family Medicine Residency Program
Jefferson Health – Abington

Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. 

This Podcast Episode does not offer CME/CE Credit. 

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

This podcast was recorded and is being used with permission of the presenters.

Learning Objectives
At the conclusion of this activity, participants should be better able to:

• Integrate recent clinical data on antipsychotic treatments and relapse prevention strategies into management plans for patients with schizophrenia
• Describe the role of muscarinic modulation in psychosis

This activity is accredited for CME/CE Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.75 hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is not commercially supported.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

This podcast was recorded and is being used with permission of the presenters.

Learning Objectives
At the conclusion of this activity, participants should be better able to:

• Examine the relationship between social media and attention
• Incorporate FDA-authorized digital therapeutics into ADHD and depression management plans based on current clinical evidence

This activity is accredited for CME/CE Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is not commercially supported.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

2. Optimal dietary patterns for healthy aging. Nature Medicine. Discussion by:
Guest:
Jessica Stieritz, MD 
Resident– Family Medicine Residency Program 
Jefferson Health – Abington

3. Amount and intensity of daily total physical activity, step count and risk of incident cancer. British Journal of Sports Medicine. Discussion by:
Guest:
William Callahan, D.O.
Associate Director – Family Medicine Residency Program
Jefferson Health – Abington

Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. 

This Podcast Episode does not offer CME/CE Credit. 

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

This podcast was recorded and is being used with permission of the presenters.

Learning Objective
At the conclusion of this activity, participants should be better able to:

• Apply evidence-based strategies to develop personalized treatment plans when managing patients with comorbid mental health disorders

This activity is accredited for CME/CE Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which does not include hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is not commercially supported.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

This podcast was recorded and is being used with permission of the presenters.

Learning Objectives
At the conclusion of this activity, participants should be better able to:

• Describe the impact of comorbid mental health diagnoses on patient outcomes
• Employ strategies to aid in the differential diagnosis of patients who present with symptoms suggestive of multiple mental health conditions

This activity is accredited for CME/CE Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is not commercially supported.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

2. Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis. New England Journal of Medicine. Discussion by:
Guest:
Amreen Syed, DO 
Resident– Family Medicine Residency Program
Jefferson Health – Abington

3. Intranasal Versus Oral Treatments for Allergic Rhinitis: A Systematic Review With Meta-Analysis Journal of Allergy and Clinical Immunology in Practice3. Discussion by:
Guest:
Michelle Buchbinder, MD
Resident – Family Medicine Residency Program 
Jefferson Health – Abington

Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. 

This Podcast Episode does not offer CME/CE Credit. 

Send us a text about this episode.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

2. Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity. New England Journal of Medicine. Discussion by:
Guest:
Christopher M. Kramer, MD 
George A. Beller/Lantheus Medical Imaging 
Distinguished Professor of Cardiovascular Medicine 
Chief of the Cardiovascular Division 
UVA Health

3. Screening for Osteoporosis to Prevent Fractures
US Preventive Services Task Force Recommendation Statement. Discussion by:
Guest:
Anupriya Grover-Wenk, DO
Faculty– Family Medicine Residency Program
Jefferson Health – Abington

Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. 

This Podcast Episode does not offer CME/CE Credit. 

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

Learning Objectives
At the conclusion of this activity, participants should be better able to:

• Assess the efficacy and safety profile of approved agents for EoE, with a focus on swallowed corticosteroids, in the management of EoE
• Apply evidence-based guidelines to optimize treatment outcomes and improve the quality of life for patients with EoE

This activity is accredited for CME/CE Credit
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.50 contact hours (which includes 0.25 hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

Summary
In this CME/CE podcast, two gastroenterologists discuss the increasing prevalence of eosinophilic esophagitis (EoE), our evolving understanding of its pathophysiology, and its varied clinical presentation. Drs. Brooks Cash and Paul Feuerstadt also review the need for early identification of the condition, and discuss the latest American College of Gastroenterology guideline for diagnosis.

Learning Objective
At the conclusion of this activity, participants should be better able to:

• Identify common clinical presentations and diagnostic challenges to facilitate early diagnosis of EoE in diverse patient populations

This activity is accredited for CME/CE Credit
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.50 contact hours (which includes 0 hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

This podcast was recorded and is being used with permission of the presenters.

Learning Objectives
At the conclusion of this activity, participants should be better able to:

• Describe the mechanism of action of psychedelic therapeutics
• Review clinical trial data regarding the use of psychedelic treatments in MDD

This activity is accredited for CME/CE Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.75 hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is not commercially supported.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Gerald Maguire discuss the benefits of exercise on both physical and mental health. Throughout the episode, they go through the research that supports the benefits of exercise, as well as provide practical strategies to encourage your patients to adopt exercise into their lifestyles.

This podcast was recorded and is being used with permission of the presenters.

Learning Objectives
At the conclusion of this activity, participants should be better able to:

• Describe the impact of exercise on mental health
• Review data from prospective studies investigating the relationship between exercise and depression

This activity is accredited for CME/CE Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is not commercially supported.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

2. Risk of dementia associated with anticholinergic drugs for overactive bladder in adults aged ≥55 years – BMJ Medicine. Discussion by:
Guest:
Kimberly Alfonso, MD, 
Resident– Family Medicine Residency Program
Jefferson Health – Abington

3. Fluoride Exposure and Children’s IQ Scores A Systematic Review and Meta-Analysis . JAMA Pediatrics 2024. Discussion by:
Guest:
Elyssa Heisey, DO
Resident– Family Medicine Residency Program
Jefferson Health – Abington

Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. 

This Podcast Episode does not offer CME/CE Credit. 

Send us a text about this episode.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

• Identify practical aspects of using potassium binders for treating hyperkalemia and optimizing GDMT to achieve equitable care for patients with HF and CKD

This activity is accredited for CME/CE Credit
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is supported by an educational grant from AstraZeneca Pharmaceuticals.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

Drs. Javed Butler and Neil Skolnik provide guidance on which patients are most at risk and review the use of potassium binders that can manage hyperkalemia without compromising the crucial use of guideline-directed medical therapy (GDMT). By the end of this podcast episode, listeners will feel much more confident in their ability to safely and effectively address hyperkalemia in patients with heart failure or CKD.

Learning Objectives
At the conclusion of this activity, participants should be better able to:

• Describe the disparities and clinical implications of hyperkalemia in patients with HF and CKD in terms of optimizing guideline-directed medical therapy (GDMT) and outcomes
• Discuss the safety and effectiveness of potassium binders in reducing potassium and optimizing GDMT in patients with HF and CKD

This activity is accredited for CME/CE Credit
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is supported by an educational grant from AstraZeneca Pharmaceuticals.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

This podcast was recorded and is being used with permission of the presenters.

Learning Objective
At the conclusion of this activity, participants should be better able to:

• Discuss psychiatric management considerations for patients with complex comorbidities in your clinical practice.

This activity is accredited for CME/CE Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.25 hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is not commercially supported.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

• Review the latest advances in ADHD, MDD, bipolar disorder, and schizophrenia

This activity is accredited for CME/CE Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which includes 0.50 hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is not commercially supported.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

• Develop a treatment plan for managing patients with AD and/or PN based on current guidelines and evolving clinical data, including specialty referral when appropriate
• Apply communication strategies to facilitate SDM in the management of patients with AD and PN to improve adherence and outcomes

This activity is accredited for CME/CE Credit
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This activity is supported by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals, Inc.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

• Recognize the similarities and differences in the clinical presentations, symptoms, and triggers of AD and PN, including in patients with skin of color
• Describe the role of type 2 inflammation in the pathophysiology of AD and PN

This activity is accredited for CME/CE Credit
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which does not include hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This activity is supported by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals, Inc.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

2. Cervical Cancer: Screening – Draft statement of the U.S. Preventive Services Task Force. Discussion by:
Guest:
Amy Clouse 
Associate Clinical Professor 
Sidney Kimmell Medical College of Thomas Jefferson University  
Associate Director - Family Medicine Residency Program
Jefferson Health – Abington

3. Chocolate intake and risk of type 2 diabetes: prospective cohort studies. The British Medical Journal 2024. Discussion by: 
Guest:
Elyssa Heisey, DO 
Resident– Family Medicine Residency Program
Jefferson Health – Abington

Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. 

This Podcast Episode does not offer CME/CE Credit. 

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

Summary
Adult ADHD is a neurodevelopmental disorder that often persists from childhood into adulthood, affecting attention, impulsivity, and executive function. Despite increased awareness, ADHD in adults remains underdiagnosed and undertreated, presenting unique challenges in clinical practice. This presentation focuses on strategies to address these challenges, drawing insights from recent data and provides our experts recommendations.

In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic discuss key findings from the CDC report on adult ADHD, including trends in prevalence, diagnostic gaps, and barriers to effective treatment. They also explore the latest research on gender differences in ADHD, emphasizing how these disparities impact diagnosis and treatment approaches. Our experts highlight the need for tailored strategies to ensure more accurate and effective care, especially given that women are often diagnosed later in life and may experience different symptom presentations than men.

This podcast was recorded and is being used with permission of the presenters.

Learning Objectives
At the conclusion of this activity, participants should be better able to:

• Review key insights from the CDC report regarding the prevalence, diagnosis trends, and treatment challenges of ADHD in adults
• Examine the latest data on gender differences in ADHD diagnosis and treatment

This activity is accredited for CME/CE Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is not commercially supported.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

• Describe the correct diagnostic algorithm for suspected ATTR, including interpretation of the monoclonal protein screen and indications for biopsy and genetic testing.
• Initiate appropriate management, including disease-directed therapy and appropriate cardiac care, or referral when indicated.

This activity is accredited for CME/CE Credit
Association of Black Cardiologists, Inc. (ABC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Association of Black Cardiologists, Inc. designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and ABC. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.25 contact hours (which does not include hours of pharmacology).

In support of improving patient care, this activity has been planned and implemented by Haymarket Medical Education (HME) and NACE. Haymarket Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This knowledge-based activity JA4008232-9999-24-043-H01-P qualifies for 0.25 contact hours (0.025 CEUs) of continuing pharmacy education credits.

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is supported by an educational grant from Alnylam Pharmaceuticals, Inc., and an educational grant from AstraZeneca Pharmaceuticals.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

Learning Objective
At the conclusion of this activity, participants should be better able to:

• Explore strategies to simplify management and optimally improve outcomes for patients with TD

This activity is accredited for CME/CE Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.50 hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is supported by an educational grant from Neurocrine Biosciences.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

2. Screen Use at Bedtime and Sleep Duration and Quality Among Youths
– JAMA Pediatrics 2024. Discussion by:
Guest:
Conor Bradley MD 
Resident– Family Medicine Residency Program
Jefferson Health – Abington

3. Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis . New England Journal of Medicine. Discussion by:
Guest:
Michelle Buchbinder, MD 
Resident– Family Medicine Residency Program
Jefferson Health – Abington

Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. 

This Podcast Episode does not offer CME/CE Credit. 

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

This podcast was recorded and is being used with permission of the presenters.

Learning Objectives
At the conclusion of this activity, participants should be better able to:

• Identify the key mechanisms of the gut-brain axis influence on brain disorders.
• Discuss ways of incorporating understanding of gut dysbiosis into comprehensive treatment of psychiatric disorders.

This activity is accredited for CME/CE Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is not commercially funded.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

• Describe the correct diagnostic algorithm for suspected ATTR, including interpretation of the monoclonal protein screen and indications for biopsy and genetic testing
• Initiate appropriate management, including disease-directed therapy and appropriate cardiac care, or referral when indicated

This activity is accredited for CME/CE Credit
Association of Black Cardiologists, Inc. (ABC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Association of Black Cardiologists, Inc. designates this enduring material for a maximum of 0.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and ABC. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.25 contact hours (which does not include hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is supported by an educational grant from Alnylam Pharmaceuticals Inc., and an educational grant from AstraZeneca Pharmaceuticals.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

Vesicular monoamine transporter type 2 (VMAT2) inhibitors are now available in the United States for managing dyskinesia syndromes, each with a slightly different range of approved indications. VMAT2 inhibitors are agents that cause a depletion of neuroactive peptides such as dopamine in nerve terminals and are used to treat chorea due to neurodegenerative diseases or dyskinesias due to neuroleptic medications (tardive dyskinesia).

In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic discuss the structural and pharmacokinetic differences between these agents, understanding how they modulate dopamine levels at hypersensitive D2 receptors, common in TD. The program emphasizes the importance of VMAT2 inhibition and its interaction with antipsychotic medications.

This podcast was recorded and is being used with permission of the presenters.

Learning Objective
At the conclusion of this activity, participants should be better able to:

• Examine the pharmacologic differences between the various VMAT2 inhibitors

This activity is accredited for CME/CE Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.50 hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is supported by an educational grant from Neurocrine Biosciences.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

2. A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening– NEJM 2024. Discussion by:
Guest:
Mathew Clark, MD 
Clinical Professor at the Sidney Kimmel medical college of 
Thomas Jefferson University
Associate Director Family Medicine Residency Program 
Jefferson Health - Abington

3. Mindfulness Meditation vs Escitalopram for Treatment of Anxiety Disorders
Secondary Analysis of a Randomized Clinical Trial. JAMA Network Open Discussion by:
Guest:
Kim Alfonzo, MD 
Resident– Family Medicine Residency Program
Jefferson Health – Abington

Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. 

This Podcast Episode does not offer CME/CE Credit. 

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

Summary
Schizophrenia is a chronic and debilitating mental illness that significantly affects not only the health, well-being, and functioning of patients but also their surrounding environment. Promoting resilience is essential for enhancing health as well as treating mental health issues. A fresh perspective on schizophrenia emphasizes early intervention, symptom enhancement, relapse prevention, functional advancement, and quality of life improvement. The importance of personalized care to improve functional outcomes for individuals living with the condition gain insights into the DARE approach:

1. Detection – The importance of early detection and intervention in reducing the burden of schizophrenia and increasing recovery chances.
2. Adherence – Shared decision-making for optimal medication choice, focusing on balancing efficacy and minimizing adverse effects that can lead to nonadherence (e.g., sedation, weight gain).
3. Recovery – Functional recovery, quality of life, and achieving personal life goals as key outcomes in treatment.
4. Engagement – Supporting patients in leading purposeful and meaningful lives.

In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic discuss the DARE approach and how shifting the goals of schizophrenia treatment toward not just response and remission but full recovery and resilience, underscore a holistic approach to mental health. 

Learning Objectives
At the conclusion of this activity, participants should be better able to:

• Evaluate the latest advancements in functional domains for schizophrenia treatment.
• Discuss personalized treatment to improve functional outcomes for individuals living with schizophrenia.

This activity is accredited for CME/CE Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.
Disclosure of Commercial Support
This educational activity is not commercially funded.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

2. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity - (The SURMOUNT OSA Trial) – NEJM 2024. Discussion by:
Guest:
Atul Malhotra, MD 
Professor of Pulmonary Critical Care & Sleep Medicine 
Previous at the University of California, San Diego.

3. Relative vaccine effectiveness of high-dose vs standard-dose influenza vaccines in preventing hospitalization and mortality: A meta-analysis of the evidence. Journal of Infection July 2024. https://doi.org/10.1016/j.jinf.2024.106187 Discussion by:
Guest:
Anupriya Grover-Wenk, MD
Faculty– Family Medicine Residency Program 
Jefferson Health – Abington

Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. 

This Podcast Episode does not offer CME/CE Credit. 

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

Learning Objectives
At the conclusion of this activity, participants should be better able to:

• Distinguish mixed mood states associated with Bipolar I, Bipolar II, and MDD
• Review existing evidence pertaining to efficacy and tolerability/safety of treatments for Bipolar I, Bipolar II, and MDD with mixed features

This activity is accredited for CME/CE Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is not commercially funded.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

Listen to Dr. Ridker as he will delve into the critical role of inflammation in cardiovascular and chronic kidney disease, with a focus on the predictive value of hsCRP as a biomarker for ASCVD and CKD risk. Dr. Ridker explores emerging strategies to address inflammation, and how these advancements could potentially reduce cardiovascular risk and improve patient outcomes.

Learning Objective
At the conclusion of this activity, participants should be better able to:

• Recognize the role of hsCRP as a biomarker in evaluating the risk of ASCVD and CKD
• Identify the role of current and emerging agents, based on their mechanism of action, to target inflammation and potentially reduce cardiovascular risk

This activity is accredited for CME/CE Credit
Association of Black Cardiologists, Inc. (ABC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Association of Black Cardiologists, Inc. designates this enduring material for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and ABC. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which includes 0.25 hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is supported by an independent medical educational grant from Novo Nordisk.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

• Integrate multidisciplinary management for patients with fibrosing ILDs to manage comorbidities and monitor for the need for specialty center referral

This activity is accredited for CME/CE Credit
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours, which includes 0 hours of pharmacology.

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic discuss the risk-benefit profiles of available antidepressants and their efficacy for residual depressive symptoms. The faculty review the relative burden of side effects with different agents, the impact of therapies on cognitive function, and specific approaches to managing anhedonia. 

This podcast/webcast was recorded and is being used with permission of the presenters.

Learning Objectives
At the conclusion of this activity, participants should be better able to:

• Discuss the risk–benefit profile of antidepressant medications and the potential impact on residual symptoms
• Tailor MDD interventions to specific patient needs, based on the presence or risk of residual symptoms and using culturally sensitive communication, to achieve clinical remission

This activity is accredited for CME/CE Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.50 hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

In just 15 minutes, this podcast/webcast covers the latest on:

• New inhaler options: Albuterol/budesonide and smart therapy alternatives
• Montelukast: Weighing benefits against risks and boxed warnings
• Biomarkers: What to test and how to use the results to guide referrals
• Biologics: When to consider them and how to co-manage with specialists
• Practical tips: Best practices for primary care clinicians in everyday asthma management

Learning Objectives
Upon completion of this activity, learners should be able to:

• Evaluate patients with asthma to identify those with inflammatory phenotypes who are more likely to have exacerbations and severe disease
• Escalate care for patients with moderate-to-severe asthma uncontrolled on ICS-LABA

This activity is accredited for CME/CE Credit
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours, which includes 0.25 hours of pharmacology.

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

2. Association of Semaglutide With Tobacco Use Disorder in Patients With Type 2 Diabetes/ Target Trial Emulation Using Real-World Data/ Annals of Internal Medicine
Guest:
Richard Potter, MD
Resident – Family Medicine Residency Program
Jefferson Health – Abington

3. Counterfit Ozempic JAMA 
Guest:
Jasmine Walker, MD
Resident – Family Medicine Residency Program
Jefferson Health – Abington 

Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. 

This Podcast Episode does not offer CME/CE Credit. 

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

2. Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
Guest:
Richard E. Pratley , MD
Medical Director at the AdventHealth Diabetes Institute
Senior Investigator, Diabetes Program Lead at the Translational Research Institute
 
3. Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
Guest: 
Richard Potter, MD
Resident – Family Medicine Residency Program
Jefferson Health – Abington

Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. 

This Podcast Episode does not offer CME/CE Credit. 

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

• Identify ways to overcome provider and practice-based healthcare disparities in the management of patients with COPD

This activity is accredited for CME/CE Credit
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours, which includes 0 hours of pharmacology.

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

• Discuss the biology of menopausal vasomotor symptoms (VMS)
• Integrate new and emerging agents into the treatment of women with menopausal VMS, based on patient characteristics and preferences

This activity is accredited for CME/CE Credit
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours, which includes 0 hours of pharmacology.

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is supported by an independent medical educational grant from Astellas Pharma Global Development, Inc.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

• Review evolving concepts in the understanding, evaluation, and treatments of severe asthma and their implications on management

This activity is accredited for CME/CE Credit
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours, which includes 0 hours of pharmacology.

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

This podcast/webcast was recorded and is being used with permission of the presenters.

This activity is accredited for CME/CE Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.25 hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

• 2018 Guideline on the Management of Blood Cholesterol.
• 2022 ACC Expert Consensus Decision Pathway.
• CLEAR Outcomes, CVOT studies, Risk Calculators.

Helping sort these and other topics out, Dr. James Underberg and Dr. Jessica Pena discuss the top 5 learner submitted questions/topics from the recent programs on non-statin lipid management in primary prevention of ASCVD.

Learning Objectives
Upon completion of this activity, learners should be able to:

• Identify patients at high risk for ASCVD, based on risk factors and testing, who would benefit from additional lipid lowering
• Integrate evolving evidence with guidelines and expert recommendations in the use of non-statin therapies for primary prevention of ASCVD in patients at high risk

This activity is accredited for CME/CE Credit
Association of Black Cardiologists, Inc. (ABC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Association of Black Cardiologists, Inc. designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and ABC. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is supported in part by an educational grant from Esperion Therapeutics, Inc. and an independent educational grant from Novartis Pharmaceuticals Corporation.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

• Discuss the role of epithelial cytokines in the inflammatory response of asthma and other airway diseases
• Select appropriate agents to target the ongoing inflammatory cascade in patients with severe asthma

This activity is accredited for CME/CE Credit
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hour (which includes 0 hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is supported by an independent educational grant from AstraZeneca Pharmaceuticals.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

Host
Corinne R. Young, MSN, FNP-C, FCCP
Director of APP and Clinical Services, Colorado Springs Pulmonary Consultants
President, APAPP, Colorado Springs, CO

Corinne Young is a Nurse Practitioner began working in the area of pulmonary disease in California in 2005. Since 2011, she has worked in a private pulmonary practice in Colorado Springs, Colorado. Involvement and the representation of advanced practice providers in the pulmonary world has been an important priority for Corinne.  To that end,  Corinne is the Founder and President of the Association of Pulmonary Advanced Practice Providers.

In addition to her work with APAPP, Corinne is currently one of ten NPs nationwide to become a Fellow of the American College of Chest Physicians. She works closely with the American College of Chest Physicians CHEST programs, and serves on the Interprofessional Team Network, Clinical Research Network, and on the Executive Programing Committee. Additionally, Corinne serves on the American Board of Internal Medicine Pulmonary Disease Board.

This Podcast episode does not offer CME/CE Credit.

Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

This podcast was recorded and is being used with permission of the presenters.

This activity is accredited for CME/CE Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is not commercially supported.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic discuss the evolving neurologic basis of depression and empower clinicians with convergent evidence about the pathophysiology and appropriate treatment options of “difficult-to-treat depression” (DTD) and “treatment-resistant-depression” (TRD) to inform therapeutic decisions.

This podcast/webcast was recorded and is being used with permission of the presenters.

Learning Objectives
Upon completion of this activity, learners should be able to: 

• Review the evolving genetic and neurologic basis of depression
• Distinguish between “difficult-to-treat” and “treatment-resistant” depression to inform therapeutic decisions, and appropriate treatment options

This activity is accredited for CME/CE Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does includes 0.25 hours of pharmacology).

For additional information about the accreditation of this program, contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is not commercially supported.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

• Discuss the biology of menopausal VMS
• Integrate new and emerging agents into the treatment of women with menopausal VMS, based on patient characteristics and preferences

This activity is accredited for CME/CE Credit
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.50 contact hours (which includes 0.25 hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is supported by an independent medical educational grant from Astellas Pharma Global Development, Inc.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

In this podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic discuss the impact of stress, hormones and mood, as understanding these hormonal influences is crucial for managing mood disorders, improving cognitive function, and promoting overall well-being.

This podcast was recorded and is being used with permission of the presenters.

Learning Objectives
Upon completion of this activity, learners should be able to: 

• Summarize the role of hormonal changes and their impact on mood and cognition
• Discuss recent developments that improve outcomes of hormonally triggered problems with mood or cognition

This activity is accredited for CME/CE Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include any hours of pharmacology).

For additional information about the accreditation of this program, contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is not commercially supported.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

In this podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic discuss the impact of resilience as well as strategies such as cognitive-behavioral therapy, exercise, social support networks, and healthy lifestyle habits which have been shown to promote neuroplasticity and enhance resilience by positively impacting epigenetic processes. By understanding and leveraging these interconnected concepts, individuals can empower themselves to navigate life's challenges with greater resilience and adaptability.

This podcast was recorded and is being used with permission of the presenters.

Learning Objectives
Upon completion of this activity, learners should be able to: 

• Summarize how trauma and resilience impact epigenetics and neuroplasticity
• Discuss clinical interventions and strategies to improve resilience within your practice

This activity is accredited for CME/CE Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include any hours of pharmacology).

For additional information about the accreditation of this program, contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Please review faculty and planner disclosures here.

Disclosure of Commercial Support
This educational activity is not commercially supported.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

Guest
Tyler Kuhk, MN
Nurse Practitioner
Overlake Medical Center & Clinics - Pulmonary Medicine
Bellevue, Washington.

Tyler Kuhk is an Adult-Gerontology Nurse Practitioner at Overlake Medical Center & Clinics – Pulmonary Medicine in Bellevue, Washington. He attended Lakehead University in Thunder Bay, Ontario, Canada where he obtained his Bachelor of Science in Nursing Degree in 2010. During his undergraduate studies he was the President of the Lakehead University Nursing Association (LUNA) and later became heavily involved in the Canadian Nursing Students’ Association (CNSA) where he served as Ontario Regional Director (2007-2008) and as President (2008-2009). As President he was also a board member of both the Canadian Nurses Association (CNA) and Canadian Federation of Nurses Unions (CFNU). Tyler began his career at the Thunder Bay Regional Health Sciences Centre (TBRHSC) as a Medical-Surgical Registered Nurse, specializing in orthopedics and cardiac-telemetry. He also worked casually in a long-term care facility where he continued to foster an appreciation for gerontology. When the opportunity presented itself to relocate to the Pacific Northwest, Tyler transitioned into the critical care environment for the next six years, practicing in Tacoma, Everett and Bellevue, mainly in the cardiovascular ICU setting. In 2013 he decided to embark on a new journey within nursing and started his Master of Nursing Degree at the University of Toronto in the Adult-Gerontology Nurse Practitioner stream. During his studies he trained in a variety of settings including inpatient cardiology, inpatient internal medicine and outpatient pulmonology. He graduated in November 2015 and began practicing in outpatient pulmonology in April 2016. His main areas of clinical interest include chronic cough, chronic obstructive pulmonary disease and asthma.

Host
Corinne R. Young, MSN, FNP-C, FCCP
Director of APP and Clinical Services, Colorado Springs Pulmonary Consultants
President, APAPP, Colorado Springs, CO

Corinne Young is a Nurse Practitioner began working in the area of pulmonary disease in California in 2005. Since 2011, she has worked in a private pulmonary practice in Colorado Springs, Colorado. Involvement and the representation of advanced practice providers in the pulmonary world has been an important priority for Corinne.  To that end,  Corinne is the Founder and President of the Association of Pulmonary Advanced Practice Providers.

In addition to her work with APAPP, Corinne is currently one of ten NPs nationwide to become a Fellow of the American College of Chest Physicians. She works closely with the American College of Chest Physicians CHEST programs, and serves on the Interprofessional Team Network, Clinical Research Network, and on the Executive Programing Committee. Additionally, Corinne serves on the American Board of Internal Medicine Pulmonary Disease Board.

This Podcast episode does not offer CME/CE Credit.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

• Identify patient and clinician barriers to management of menopausal symptoms

• Consultant: Novo Nordisk (obesity), Lilly (obesity), Acella (thyroid), Currax (obesity), Boehringer Ingelheim (obesity), WW (obesity), Gelesis (obesity - relationship has ended)
• Speaker: Novo Nordisk (obesity), Lilly (obesity), Acella (thyroid), Currax (obesity)
• Receipt of Royalty: Springer (obesity - relationship has ended), Amazon (fiction)

• Scientific Advisory Board: Astellas (women’s health), Natera (women’s health)
• Review Panel: SRI (professional organization)

• Consultant: Astellas Pharma, MenoGeniX, Ansh Labs
• All disclosures are related to women's health.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

1. Aspirin and Cardiovascular Risk in Individuals With Elevated Lipoprotein(a)
Guest:
Brad Rivotto, MD
Resident – Family Medicine Residency Program
Jefferson Health – Abington
 
2. Triple – Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
Julio Rosenstock, MD
Senior Scientific Advisor for Velocity Clinical Research,
Director of Velocity’s site at Medical City Dallas,
Clinical Professor of Medicine at the University of Texas Southwestern Medical Center, Dallas.

3. Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial.
Amrin Syed, DO 
Resident – Family Medicine Residency Program 
Jefferson Health – Abington

Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. 

This Podcast Episode does not offer CME/CE Credit. 

Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

Guest
Cori Fratelli, RN, MSN, FNP-C
Nurse Practitioner
Division of Pulmonary, Critical Care & Sleep Medicine
Department of Medicine

I have a unique background in both basic science and clinical research, which has informed my interest in clinical medicine. My past basic science research includes asthma, airway hyperresponsiveness, cystic fibrosis, and lung cancer. My past clinical research includes COPD and interstitial lung disease (ILD). Presently, I am interested in how research translates into personalized medicine. My clinical focus is mainly ILD, but I also see general pulmonary medicine patients, as needed.

Host
Corinne R. Young, MSN, FNP-C, FCCP
Director of APP and Clinical Services, Colorado Springs Pulmonary Consultants
President, APAPP, Colorado Springs, CO

Corinne Young is a Nurse Practitioner began working in the area of pulmonary disease in California in 2005. Since 2011, she has worked in a private pulmonary practice in Colorado Springs, Colorado. Involvement and the representation of advanced practice providers in the pulmonary world has been an important priority for Corinne.  To that end,  Corinne is the Founder and President of the Association of Pulmonary Advanced Practice Providers.

In addition to her work with APAPP, Corinne is currently one of ten NPs nationwide to become a Fellow of the American College of Chest Physicians. She works closely with the American College of Chest Physicians CHEST programs, and serves on the Interprofessional Team Network, Clinical Research Network, and on the Executive Programing Committee. Additionally, Corinne serves on the American Board of Internal Medicine Pulmonary Disease Board.

This Podcast episode does not offer CME/CE Credit.

Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

1. Long-Term Leisure-Time Physical Activity Intensity and All-Cause and Cause-Specific Mortality: A Prospective Cohort of US Adults
Guest:
Philip Lieberman, MD,
Resident – Family Medicine Residency Program
Jefferson Health – Abington
 
2. Association between changes in carbohydrate intake and long term weight changes: prospective cohort study
Walter C. Willett, M.D., Dr. P.H.
Professor of Epidemiology and Nutrition at Harvard T.H. Chan School of Public Health, 
Professor of Medicine, Harvard Medical School

3. Clinically Important Benefits and Harms of Monoclonal Antibodies Targeting Amyloid for the Treatment of Alzheimer Disease: A Systematic Review and Meta-Analysis
Richard Potter, MD, Resident – Family Medicine Residency Program 
Jefferson Health – Abington

Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. 

This Podcast Episode does not offer CME/CE Credit. 

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

Guest
Cori Fratelli, RN, MSN, FNP-C
Nurse Practitioner
Division of Pulmonary, Critical Care & Sleep Medicine
Department of Medicine

I have a unique background in both basic science and clinical research, which has informed my interest in clinical medicine. My past basic science research includes asthma, airway hyperresponsiveness, cystic fibrosis, and lung cancer. My past clinical research includes COPD and interstitial lung disease (ILD). Presently, I am interested in how research translates into personalized medicine. My clinical focus is mainly ILD, but I also see general pulmonary medicine patients, as needed.

Host
Corinne R. Young, MSN, FNP-C, FCCP
Director of APP and Clinical Services, Colorado Springs Pulmonary Consultants
President, APAPP, Colorado Springs, CO

Corinne Young is a Nurse Practitioner began working in the area of pulmonary disease in California in 2005. Since 2011, she has worked in a private pulmonary practice in Colorado Springs, Colorado. Involvement and the representation of advanced practice providers in the pulmonary world has been an important priority for Corinne.  To that end,  Corinne is the Founder and President of the Association of Pulmonary Advanced Practice Providers.

In addition to her work with APAPP, Corinne is currently one of ten NPs nationwide to become a Fellow of the American College of Chest Physicians. She works closely with the American College of Chest Physicians CHEST programs, and serves on the Interprofessional Team Network, Clinical Research Network, and on the Executive Programing Committee. Additionally, Corinne serves on the American Board of Internal Medicine Pulmonary Disease Board.

This Podcast episode does not offer CME/CE Credit.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

1. Strategies to Increase Cervical Cancer Screening With Mailed Human Papillomavirus Self-Sampling Kits: A Randomized Clinical Trial
Guest:
Amy Clouse, MD
Associate Director
Family Medicine Residency
Jefferson Health – Abington.
 
2. Association Between Changes in Carbohydrate Intake and Long Term Weight Changes: Prospective Cohort Study
Guest:
Walter C. Willett, MD, PhD
Professor of Epidemiology and Nutrition
Harvard T.H. Chan School of Public Health 

3. Guidelines of care for the management of atopic dermatitis in adults with topical therapies – Journal of the American Academy of Dermatology
Guest: 
Catherine McCormick, DO  
Resident in the Family Medicine Residency
Jefferson Health – Abington.  

Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. 

This Podcast Episode does not offer CME/CE Credit. 

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

1. Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial –
The New England Journal of Medicine
Guest:
Marrisa Norden, DO
Resident
Family Medicine Residency
Jefferson Health-Abington, Abington, PA

2. Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation A
Randomized Clinical Trial - JAMA
Guest:
Richard Potter, MD
Resident
Family Medicine Residency
Jefferson Health-Abington, Abington, PA

3. Sedentary Behavior and Incident Dementia Among Older Adults - JAMA
Guest: 
Michael Devano, DO
Resident
Family Medicine Residency
Jefferson Health-Abington, Abington, PA

Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. 

This Podcast Episode does not offer CME/CE Credit. 

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

• Diagnose HoFH based on clinical criteria and genetic testing when indicated
• Implement, or refer patients for, cascade screening and the appropriate pharmacologic treatment of HoFH
• Recognize and address patient and family needs to overcome barriers to care in HoFH

This activity is accredited for CME/CE Credit
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which include 0 hours of pharmacology).

Click on the link to view the summary of individual disclosures.
https://www.naceonline.com/courses/deep-dive-into-five-answering-your-questions-about-hofh

Disclosure of Commercial Support
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

Guest
Susan Wilxon, MD
 Dr. Susan Wilcox, M.D., attended medical school at Washington University School of Medicine and trained in Emergency Medicine in the Harvard Affiliated Emergency Medicine Residency, graduating in 2008. After residency, she completed an Anesthesia Critical Care fellowship at Massachusetts General Hospital.  Since finishing her training in 2009, she divided her time between the Emergency Department and critical care, working in Surgical ICUs, Medical ICUs, and long-term vent units. In July 2017, she assumed the role of the Chief of the newly formed Division of Critical Care within the Department of Emergency Medicine MGH. In addition to attending in the Emergency Department, she also attends in the Heart Center ICU and serves as the Associate Chief Medical Officer of Boston MedFlight.

Host
Corinne R. Young, MSN, FNP-C, FCCP
Director of APP and Clinical Services, Colorado Springs Pulmonary Consultants
President, APAPP, Colorado Springs, CO

Corinne Young is a Nurse Practitioner began working in the area of pulmonary disease in California in 2005. Since 2011, she has worked in a private pulmonary practice in Colorado Springs, Colorado. Involvement and the representation of advanced practice providers in the pulmonary world has been an important priority for Corinne.  To that end,  Corinne is the Founder and President of the Association of Pulmonary Advanced Practice Providers.

In addition to her work with APAPP, Corinne is currently one of ten NPs nationwide to become a Fellow of the American College of Chest Physicians. She works closely with the American College of Chest Physicians CHEST programs, and serves on the Interprofessional Team Network, Clinical Research Network, and on the Executive Programing Committee. Additionally, Corinne serves on the American Board of Internal Medicine Pulmonary Disease Board.

This Podcast episode does not offer CME/CE Credit.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

• Incorporate early use of GLP-1 RA therapy in appropriate patients with T2D using a holistic approach, considering administration route and optimal dosing
• Overcome barriers to GLP-1 RA uptake and medication adherence in T2D through patient counseling to manage adverse effects

This activity is accredited for CME/CE Credit
Association of Black Cardiologists, Inc. (ABC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Association of Black Cardiologists, Inc. (ABC) designates this enduring material for a maximum of 0.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and ABC. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).

For additional information about the accreditation of this program, contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Dr. Taub financial relationships:
Consultant: Amgen, Bayer, Boehringer Ingelheim, Novartis, Novo Nordisk, Esperion, Merck, Sanofi, Medtronic
Contracted Research: Amgen, Novartis
All her disclosures are related to cardiology

Dr. Morris financial relationships:
Consultant and advisor: Acorai, Regeneron, Merck
Speaker: Abbott, BI Lilly, Cytokinetics, Edwards Lifesciences, Ionis
Contracted Research: Boston Scientific, Cytokinetics, Ionis, Merck, Myokardia, Novartis
Stocks: Gilead Sciences
All her disclosures are related to heart failure.

All of the relevant financial relationships listed for these individuals have been mitigated.

Association of Black Cardiologists Planning Committee
Tierra Dillenburg has no relevant conflicts of interest with any ACCME-defined commercial interest.

Faculty, planners, guest patient(s) (if applicable), and moderators for this educational activity not listed in the Summary of Individual Disclosures above have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Disclosure of Commercial Support
This educational activity is supported by an independent educational grant from Novo Nordisk Inc.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

Guest
Martha Kingman, FNP-C, DNP
 Family Nurse Practitioner in the pulmonary hypertension clinic at the University of Texas Southwestern Medical Center at Dallas.

She is presently serving as sub-investigator in numerous ongoing pulmonary hypertension clinical trials. She is a member of the speakers’ bureaus for Actelion, United Therapeutics, and Gilead, and she gives her time and expertise to several nursing advisory boards. Martha is an active member of the PH Professional Network, having previously served on the national conference planning committee, and she has chaired the Research and Publications Committee of the Pulmonary Hypertension Association. She currently serves on the Editorial Board of Advances in Pulmonary Hypertension, the PHA’s journal.

Dr. Kingman earned a bachelor’s degree from Tulsa University School of Nursing in Tulsa, following which she worked in emergency department settings as a staff nurse and then as director of the ED after which she obtained her Master of Science in Nursing degree from Texas Woman’s University in Dallas. When she became board certified as a Family Nurse Practitioner, she accepted the job of nurse practitioner in the pulmonary department at UTSW Medical Center and remains in that role today.  The majority of her clinical work involves the follow-up outpatient care of a large group of pulmonary hypertension patients at UTSW Medical Center. In May 2011, Dr. Kingman obtained her Doctorate in Nursing Practice from Texas Christian University.

Martha has published in the area of pulmonary hypertension and has spoken at local and national conferences.  Her main area of research interest involves the safety of intravenous prostacyclins in the hospital setting.

Host
Corinne R. Young, MSN, FNP-C, FCCP
Director of APP and Clinical Services, Colorado Springs Pulmonary Consultants
President, APAPP, Colorado Springs, CO

Corinne Young is a Nurse Practitioner began working in the area of pulmonary disease in California in 2005. Since 2011, she has worked in a private pulmonary practice in Colorado Springs, Colorado. Involvement and the representation of advanced practice providers in the pulmonary world has been an important priority for Corinne.  To that end,  Corinne is the Founder and President of the Association of Pulmonary Advanced Practice Providers.

In addition to her work with APAPP, Corinne is currently one of ten NPs nationwide to become a Fellow of the American College of Chest Physicians. She works closely with the American College of Chest Physicians CHEST programs, and serves on the Interprofessional Team Network, Clinical Research Network, and on the Executive Programing Committee. Additionally, Corinne serves on the American Board of Internal Medicine Pulmonary Disease Board.

This Podcast episode does not offer CME/CE Credit.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

This Podcast episode does not offer CME/CE Credit.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

This Podcast episode does not offer CME/CE Credit.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

This podcast was recorded and is being used with permission of the presenters.

Learning Objective
Upon completion of this activity, learners should be able to:

• Individualize the management of TD using evidence-based strategies that target uncontrolled movements

This activity is accredited for CME/CE Credit
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).

Summary of Individual Disclosures
Angela Golden has disclosed the following financial relationships:

• Consultant: SetPoint (obesity), WW (obesity)
• Advisor: Currax (obesity), Genesis (obesity), Lilly (obesity), Novo Nordisk (obesity), Acela (hypothyroidism)
• Speaker: Currax (obesity), Novo Nordisk (obesity)
• Receipt of Royalty: Amazon (fiction books), Springer (obesity book)

Greg Mattingly has disclosed the following financial relationship:

• Consultant: AbbVie, Alkermes, Axsome, Biogen, Corium, Eisai, Ironshore, Intra-Cellular, Janssen, Lundbeck, Neurocrine Biosciences, Noven, Otsuka, Redax, Roche, Sage, Sirona, Sunovion, Supernus, Takeda, Teva
• Speaker: AbbVie, Alkermes, Axsome, Corium, Intra-Cellular, Ironshore, Janssen, Lundbeck, Neurocrine Biosciences, Noven, Otsuka, Sunovion, Supernus, Takeda, Tris Pharma
• Contracted Research: AbbVie, Alkermes, Akili, Axsome, Boehringer Ingelheim, Emalex, Idorsia, Janssen, Karuna, Lumos Labs, Medgenics, Neurocrine Biosciences, NLS Pharmaceuticals, Otsuka, Redax, Relmada, Roche, Sage, Sirtsei, Sunovion, Supernus, Takeda, Teva
• All his disclosures are related to mental health

Faculty, planners, guest patient(s) (if applicable), and moderators for this educational activity not listed in the Summary of Individual Disclosures above have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Disclosure of Commercial Support
This activity is supported by an independent medical education grant from Neurocrine Biosciences, Inc.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

• Identify the early manifestations of tardive dyskinesia (TD) in patients on antipsychotic therapy
• Recognize the burden associated with untreated TD and the consequences of delayed diagnosis

This activity is accredited for CME/CE Credit
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).

Summary of Individual Disclosures
Angela Golden has disclosed the following financial relationships:

• Consultant: SetPoint (obesity), WW (obesity)
• Advisor: Currax (obesity), Genesis (obesity), Lilly (obesity), Novo Nordisk (obesity), Acela (hypothyroidism)
• Speaker: Currax (obesity), Novo Nordisk (obesity)
• Receipt of Royalty: Amazon (fiction books), Springer (obesity book)

Greg Mattingly has disclosed the following financial relationship:

• Consultant: AbbVie, Alkermes, Axsome, Biogen, Corium, Eisai, Ironshore, Intra-Cellular, Janssen, Lundbeck, Neurocrine Biosciences, Noven, Otsuka, Redax, Roche, Sage, Sirona, Sunovion, Supernus, Takeda, Teva
• Speaker: AbbVie, Alkermes, Axsome, Corium, Intra-Cellular, Ironshore, Janssen, Lundbeck, Neurocrine Biosciences, Noven, Otsuka, Sunovion, Supernus, Takeda, Tris Pharma
• Contracted Research: AbbVie, Alkermes, Akili, Axsome, Boehringer Ingelheim, Emalex, Idorsia, Janssen, Karuna, Lumos Labs, Medgenics, Neurocrine Biosciences, NLS Pharmaceuticals, Otsuka, Redax, Relmada, Roche, Sage, Sirtsei, Sunovion, Supernus, Takeda, Teva
• All his disclosures are related to mental health

Faculty, planners, guest patient(s) (if applicable), and moderators for this educational activity not listed in the Summary of Individual Disclosures above have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Disclosure of Commercial Support
This activity is supported by an independent medical education grant from Neurocrine Biosciences, Inc.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

• Review emerging data, including real-world and long-term extension studies, on biologic treatments for patients with severe asthma.
• Individualize biologic therapy selection for patients with severe asthma based on phenotype, comorbidities, and patient preferences.

This activity is accredited for CME/CE Credit.
Provided by the National Association for Continuing Education in partnership with the Association for Pulmonary Advanced Practice Providers.

The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.5 contact hour (which includes 0.5 hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.

Summary of Individual Disclosures
Dr. Lugogo has disclosed the following financial relationship:
Consultant: Amgen, AstraZeneca, Avillion, Genentech, GSK, Novartis, Regeneron, Sanofi, and Teva
Advisor: Amgen, AstraZeneca, Genentech, GSK, Regeneron, Sanofi, and Teva
Speaker: Honoraria for non-speaker’s bureau presentations from GSK and AstraZeneca
Contracted Research: Research support from Amgen, AstraZeneca, Avillion, Evidera, Gossamer Bio, Genentech, GSK, Janssen (COVID vaccine trials), Regeneron, Sanofi, Novartis and Teva was provided to my institution

All of her disclosures are related to asthma.

Dr. Maselli has disclosed the following financial relationships:
Consultant: Amgen (asthma), Regeneron/Sanofi (asthma), AstraZeneca (asthma, COPD), GSK (asthma, COPD)
Advisor: Amgen (asthma), Regeneron/Sanofi (asthma), AstraZeneca (asthma, COPD), GSK (asthma, COPD)
Speaker: Amgen (asthma), Regeneron/Sanofi (asthma), AstraZeneca (asthma, COPD), GSK (asthma, COPD)

Dr. Sherman has no relevant financial relationships to disclose.

Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.